Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
OtherBASIC SCIENCE INVESTIGATIONS

Indication for Different Mechanisms of Kidney Uptake of Radiolabeled Peptides

Martin Gotthardt, Julliëtte van Eerd-Vismale, Wim J.G. Oyen, Marion de Jong, Hanwen Zhang, Edgar Rolleman, Helmut R. Maecke, Martin Béhé and Otto Boerman
Journal of Nuclear Medicine April 2007, 48 (4) 596-601; DOI: https://doi.org/10.2967/jnumed.106.036020
Martin Gotthardt
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Julliëtte van Eerd-Vismale
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wim J.G. Oyen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marion de Jong
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hanwen Zhang
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Edgar Rolleman
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Helmut R. Maecke
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Martin Béhé
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Otto Boerman
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • FIGURE 1. 
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 1. 

    (A) Renal accumulation of OCT in %IA/g 24 h after injection. Lys and GF significantly inhibit renal accumulation of OCT. Combination of both is more efficient in comparison with the single substances. (B) PGA does not show significant reduction of OCT uptake, whereas Lys (serving as control) does.

  • FIGURE 2. 
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 2. 

    (A) Renal accumulation of MG in %IA/g 24 h after injection. GF and PGA significantly inhibit tubular accumulation of MG, whereas Lys does not. (B) Combination of GF and PGA does not exceed efficacy of PGA alone.

  • FIGURE 3. 
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 3. 

    Renal accumulation of BOM in %IA/g 24 h after injection. BOM shows pattern comparable to that of MG as renal uptake can be reduced by PGA and GF, whereas Lys is not effective.

  • FIGURE 4. 
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 4. 

    Renal accumulation of EX in %IA/g 24 h after injection. EX shows same pattern of uptake inhibition as MG and BOM, indicating that uptake mechanism may be the same. Combination of PGA and GF shows additive effect (significant in comparison with single substances).

  • FIGURE 5. 
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 5. 

    Results of kidney autoradiography: (A) OCT, (B) MG, (C) EX, (D) BOM (from left to right). All compounds are colocalized in renal cortex; image quality reflects renal uptake of respective compounds.

Tables

  • Figures
    • View popup
    TABLE 1

    Overview of Influence of Different Substances on Renal Uptake of Radiopeptides

    RadiopeptideLysGFPGAGF + LysGF + PGA
    OCT
     0.97 ± 0.180.63 ± 0.070.57 ± 0.051.11 ± 0.10.49 ± 0.05Not done
     1.33 ± 0.28P < 0.01P < 0.01P = 0.14P < 0.01 (Lys)
    P = 0.01 (GF)
    MG
     12.16 ± 1.7812.11 ± 1.046.69 ± 0.781.77 ± 0.25Not done1.95 ± 0.18
     9.8 ± 0.77P = 0.57P < 0.01P < 0.01P < 0.05 (GF)
    6.89 ± 0.181.89 ± 0.14P = 0.51 (PGA)
    BOM
     0.35 ± 0.060.34 ± 0.060.3 ± 0.020.27 ± 0.03Not doneNot done
    P = 0.51P = 0.005P = 0.038
    EX
     20.52 ± 1.8621.86 ± 2.5716.68 ± 1.0114.48 ± 1.43Not done12.08 ± 1.01
    P = 0.8P < 0.01P < 0.01P < 0.01 (PGA, GF)
    • Kidney uptake values are given as mean ± SD in %IA/g. If results have not been obtained in 1 set of experiments, alternative results belonging together are given in italic. In the last 2 columns on the right, P values indicate significance in comparison with respective single substances.

PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 48 (4)
Journal of Nuclear Medicine
Vol. 48, Issue 4
April 2007
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Indication for Different Mechanisms of Kidney Uptake of Radiolabeled Peptides
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Indication for Different Mechanisms of Kidney Uptake of Radiolabeled Peptides
Martin Gotthardt, Julliëtte van Eerd-Vismale, Wim J.G. Oyen, Marion de Jong, Hanwen Zhang, Edgar Rolleman, Helmut R. Maecke, Martin Béhé, Otto Boerman
Journal of Nuclear Medicine Apr 2007, 48 (4) 596-601; DOI: 10.2967/jnumed.106.036020

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Indication for Different Mechanisms of Kidney Uptake of Radiolabeled Peptides
Martin Gotthardt, Julliëtte van Eerd-Vismale, Wim J.G. Oyen, Marion de Jong, Hanwen Zhang, Edgar Rolleman, Helmut R. Maecke, Martin Béhé, Otto Boerman
Journal of Nuclear Medicine Apr 2007, 48 (4) 596-601; DOI: 10.2967/jnumed.106.036020
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • This Month in JNM
  • PubMed
  • Google Scholar

Cited By...

  • Radiohybrid Ligands: A Novel Tracer Concept Exemplified by 18F- or 68Ga-Labeled rhPSMA Inhibitors
  • Cholecystokinin 2 Receptor Agonist 177Lu-PP-F11N for Radionuclide Therapy of Medullary Thyroid Carcinoma: Results of the Lumed Phase 0a Study
  • DOTA-MGS5, a New Cholecystokinin-2 Receptor-Targeting Peptide Analog with an Optimized Targeting Profile for Theranostic Use
  • Succinylated Gelatin Improves the Theranostic Potential of Radiolabeled Exendin-4 in Insulinoma Patients
  • Gelofusine Ameliorates Colistin-Induced Nephrotoxicity
  • Diabody Pretargeting with Click Chemistry In Vivo
  • The Glucose-Dependent Insulinotropic Polypeptide Receptor: A Novel Target for Neuroendocrine Tumor Imaging--First Preclinical Studies
  • Pharmacokinetic Properties of Peptidic Radiopharmaceuticals: Reduced Uptake of (EH)3-Conjugates in Important Organs
  • Durable Pharmacological Responses from the Peptide ShK-186, a Specific Kv1.3 Channel Inhibitor That Suppresses T Cell Mediators of Autoimmune Disease
  • Different Radioactivity Uptake between Somatostatin Analogues Labelled with 111In and 90/88Y in Rat Kidney
  • 64Cu-Labeled Peptide for PET of Breast Carcinomas Expressing the Thomsen-Friedenreich Carbohydrate Antigen
  • Alpha- versus Beta-Particle Radiopeptide Therapy in a Human Prostate Cancer Model (213Bi-DOTA-PESIN and 213Bi-AMBA versus177Lu-DOTA-PESIN)
  • Radiolabeled Bicyclic Somatostatin-Based Analogs: A Novel Class of Potential Radiotracers for SPECT/PET of Neuroendocrine Tumors
  • Renal Toxicity of Radiolabeled Peptides and Antibody Fragments: Mechanisms, Impact on Radionuclide Therapy, and Strategies for Prevention
  • Exendin-4-Based Radiopharmaceuticals for Glucagonlike Peptide-1 Receptor PET/CT and SPECT/CT
  • Biodistribution of Two Octreotate Analogs Radiolabeled with Indium and Yttrium in Rats
  • PET of Malignant Melanoma Using 18F-Labeled Metallopeptides
  • A 2-Helix Small Protein Labeled with 68Ga for PET Imaging of HER2 Expression
  • Reducing Renal Uptake of Radiolabeled Peptides Using Albumin Fragments
  • Google Scholar

More in this TOC Section

  • Design and Fabrication of Kidney Phantoms for Internal Radiation Dosimetry Using 3D Printing Technology
  • Synthesis and Biologic Evaluation of Novel 18F-Labeled Probes Targeting Prostate-Specific Membrane Antigen for PET of Prostate Cancer
  • Tumor-Specific Binding of Radiolabeled PEGylated GIRLRG Peptide: A Novel Agent for Targeting Cancers
Show more Basic Science Investigations

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire